FDA

FDA’s Approval Of A New Alzheimer’s Drug Shows What’s Wrong With The Way We Care For Frail Older Adults

FDA’s decision last week to approve a new “Alzheimer’s disease treatment,” and the buzz that surrounds it, is a symptom of all that is wrong with the way we care for frail older adults in the US. Rather than providing the supports that people with chronic conditions desperately need, and that evidence shows works, we prefer to chase butterflies. In [...]

By Howard Gleckman|2021-06-15T11:54:04-04:00June 15th, 2021|long-term care, Uncategorized|0 Comments

What Does FDA’s Approval Of A New Alzheimer’s Drug Mean?

In a highly controversial decision, the FDA gave accelerated approval to the first drug that could slow the progression of Alzheimer’s disease. But the approval does not say the FDA thinks the drug actually will treat the disease. Rather, FDA carefully states that the drug, with the chemical name aducanumab and the brand name Aduhelm, reduces a substance on the [...]

By Howard Gleckman|2021-06-07T17:50:37-04:00June 7th, 2021|dementia|5 Comments

Previous 12